Skip to Main Content

Author Details

Fernando J Corrales
National Center for Biotechnology
1988
182
40
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37302584Identification and experimental validation of druggable epigenetic targets in hepatoblastoma.J Hepatol2023
37595047CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects.Sci Adv2023
37863471Proteomic Serum Profiling of Holstein Friesian Cows with Different Pathological Forms of Bovine Paratuberculosis Reveals Changes in the Acute-Phase Response and Lipid Metabolism.J Proteome Res2023
37302584Identification and experimental validation of druggable epigenetic targets in hepatoblastoma.J Hepatol2023
37171157Mapping early serum proteome signatures of liver regeneration in living donor liver transplant cases.Biofactors2023
37545510SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling.Front Immunol2023
37863471Proteomic Serum Profiling of Holstein Friesian Cows with Different Pathological Forms of Bovine Paratuberculosis Reveals Changes in the Acute-Phase Response and Lipid Metabolism.J Proteome Res2023
37595047CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects.Sci Adv2023
37545510SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling.Front Immunol2023
37171157Mapping early serum proteome signatures of liver regeneration in living donor liver transplant cases.Biofactors2023
34758407Multi-laboratory experiment PME11 for the standardization of phosphoproteome analysis.J Proteomics2022
35884998Mapping the Serum Proteome of COVID-19 Patients; Guidance for Severity Assessment.Biomedicines2022
35629903Analysis of Serum Proteome after Treatment of Osteoporosis with Anabolic or Antiresorptive Drugs.Metabolites2022
36144184Targeted Proteomics for Monitoring One-Carbon Metabolism in Liver Diseases.Metabolites2022
35619118New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.J Exp Clin Cancer Res2022
34905173Development of a Standardized MRM Method for the Quantification of One Carbon Metabolism Enzymes.Methods Mol Biol2022
34905161Bile Processing Protocol for Improved Proteomic Analysis.Methods Mol Biol2022
34897580Monitoring one-carbon metabolism by mass spectrometry to assess liver function and disease.J Physiol Biochem2022
35020410Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria.Sci Transl Med2022
35144530Quantitative proteomic analysis of serum-purified exosomes identifies putative pre-eclampsia-associated biomarkers.Clin Proteomics2022
34758407Multi-laboratory experiment PME11 for the standardization of phosphoproteome analysis.J Proteomics2022
35154090SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS.Front Immunol2022
35629903Analysis of Serum Proteome after Treatment of Osteoporosis with Anabolic or Antiresorptive Drugs.Metabolites2022
35619118New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.J Exp Clin Cancer Res2022
36144184Targeted Proteomics for Monitoring One-Carbon Metabolism in Liver Diseases.Metabolites2022
35884998Mapping the Serum Proteome of COVID-19 Patients; Guidance for Severity Assessment.Biomedicines2022
35154090SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS.Front Immunol2022
35144530Quantitative proteomic analysis of serum-purified exosomes identifies putative pre-eclampsia-associated biomarkers.Clin Proteomics2022
34905173Development of a Standardized MRM Method for the Quantification of One Carbon Metabolism Enzymes.Methods Mol Biol2022
34905161Bile Processing Protocol for Improved Proteomic Analysis.Methods Mol Biol2022
34897580Monitoring one-carbon metabolism by mass spectrometry to assess liver function and disease.J Physiol Biochem2022
35020410Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria.Sci Transl Med2022
32932008Digging deeper into bile proteome.J Proteomics2021
34170569Splicing Factor SLU7 Prevents Oxidative Stress-Mediated Hepatocyte Nuclear Factor 4α Degradation, Preserving Hepatic Differentiation and Protecting From Liver Damage.Hepatology2021
34063716A Proteomic Approach for Systematic Mapping of Substrates of Human Deubiquitinating Enzymes.Int J Mol Sci2021
33499801Quantitative proteomics-based analyses performed on pre-eclampsia samples in the 2004-2020 period: a systematic review.Clin Proteomics2021
33708194Long-Term Liver Expression of an Apolipoprotein A-I Mimetic Peptide Attenuates Interferon-Alpha-Induced Inflammation and Promotes Antiviral Activity.Front Immunol2021
32932008Digging deeper into bile proteome.J Proteomics2021
34670092Progress Identifying and Analyzing the Human Proteome: 2021 Metrics from the HUPO Human Proteome Project.J Proteome Res2021
33708194Long-Term Liver Expression of an Apolipoprotein A-I Mimetic Peptide Attenuates Interferon-Alpha-Induced Inflammation and Promotes Antiviral Activity.Front Immunol2021
33499801Quantitative proteomics-based analyses performed on pre-eclampsia samples in the 2004-2020 period: a systematic review.Clin Proteomics2021
34670092Progress Identifying and Analyzing the Human Proteome: 2021 Metrics from the HUPO Human Proteome Project.J Proteome Res2021
34063716A Proteomic Approach for Systematic Mapping of Substrates of Human Deubiquitinating Enzymes.Int J Mol Sci2021
34170569Splicing Factor SLU7 Prevents Oxidative Stress-Mediated Hepatocyte Nuclear Factor 4α Degradation, Preserving Hepatic Differentiation and Protecting From Liver Damage.Hepatology2021
31539805Blockade of the trans-sulfuration pathway in acute pancreatitis due to nitration of cystathionine β-synthase.Redox Biol2020
32427033Analytical techniques for multiplex analysis of protein biomarkers.Expert Rev Proteomics2020
32473097The COVID-19 MS Coalition-accelerating diagnostics, prognostics, and treatment.Lancet2020
33155801UPEFinder: A Bioinformatic Tool for the Study of Uncharacterized Proteins Based on Gene Expression Correlation and the PageRank Algorithm.J Proteome Res2020
33096722Why Does COVID-19 Affect Patients with Spinal Cord Injury Milder? A Case-Control Study: Results from Two Observational Cohorts.J Pers Med2020
32931287Research on the Human Proteome Reaches a Major Milestone: >90% of Predicted Human Proteins Now Credibly Detected, According to the HUPO Human Proteome Project.J Proteome Res2020
  • 1 - 50 of 364

Recommended Authors

Royal Institute of Technology Science for Life Laboratory Stockholm Sweden.
Career Start Year 2012
Number of shared co-authors 7
Stockholm University
Career Start Year 2010
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus
Career Start Year 2009
Number of shared co-authors 1
University of California San Francisco
Career Start Year 2009
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 2008
Number of shared co-authors 6
Functional Genomics Center Zurich (FGCZ)-University of Zurich/ETH Zurich
Career Start Year 2007
Number of shared co-authors 1
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)
Career Start Year 2007
Number of shared co-authors 2
Institute for Systems Biology
Career Start Year 2003
Number of shared co-authors 2
McGill Research Centre for Studies in Aging
Career Start Year 2003
Number of shared co-authors 4
Universitatsklinikum
Career Start Year 2002
Number of shared co-authors 1
University College Dublin
Career Start Year 2002
Number of shared co-authors 0
Salk Institute for Biological Studies
Career Start Year 2000
Number of shared co-authors 10
Pacific Northwest National Laboratory
Career Start Year 2000
Number of shared co-authors 4
Center for Biomedical Research Support, The University of Texas at Austin
Career Start Year 1999
Number of shared co-authors 0
Pacific Northwest National Laboratory
Career Start Year 1999
Number of shared co-authors 4
Meilahti Clinical Proteomics Core Facility, University of Helsinki
Career Start Year 1999
Number of shared co-authors 0
Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke (CRCHUS)
Career Start Year 1999
Number of shared co-authors 2
Universite PSL, LPC CNRS UMR8249
Career Start Year 1997
Number of shared co-authors 0
Academy of Pharmacy, Xi'an Jiaotong-Liverpool University
Career Start Year 1996
Number of shared co-authors 2
University of Nebraska (UNL)
Career Start Year 1993
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1990
Number of shared co-authors 9
Inc. Research Triangle Park
Career Start Year 1987
Number of shared co-authors 0
Ribeirao Preto Medical School, University of Sao Paulo
Career Start Year 1987
Number of shared co-authors 0
Maastricht University
Career Start Year 1984
Number of shared co-authors 0
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Career Start Year 1984
Number of shared co-authors 0
Karolinska Institutet
Career Start Year 1980
Number of shared co-authors 2
Indiana University School of Medicine
Career Start Year 1979
Number of shared co-authors 0
University Medicine
Career Start Year 1974
Number of shared co-authors 3
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1964
Number of shared co-authors 16
TheScripps Research Institute
Career Start Year 1960
Number of shared co-authors 27

Collaborators

Center for Applied Medical Research (CIMA)
Co-authored papers 23
SIB Swiss Institute of Bioinformatics and University of Geneva
Co-authored papers 11
and School of Public Health, University of Michigan ann arbor
Co-authored papers 11
College of Life Sciences and Biotechnology, Yonsei University
Co-authored papers 10
Institute for Systems Biology
Co-authored papers 10
University of British Columbia
Co-authored papers 9
Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL)
Co-authored papers 8
Max-Planck-Institut fur Entwicklungsbiologie
Co-authored papers 7
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Co-authored papers 6
Smidt Heart Institute, Cedars-Sinai Medical Center
Co-authored papers 6
National Center for Biotechnology
Co-authored papers 6
The Second Hospital, Jilin University
Co-authored papers 6
Macquarie University
Co-authored papers 6
EMBL-European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 5
Medical Research Council Laboratory of Molecular Biology
Co-authored papers 5
Cancer Research Center (CSIC/USAL/IBSAL)
Co-authored papers 5
Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL)
Co-authored papers 5
Institute of Molecular Systems Biology, ETH Zurich
Co-authored papers 4
Instituto de Investigacion Sanitaria La Fe
Co-authored papers 4
Stanford University
Co-authored papers 4
Biodesign Institute, Arizona State University
Co-authored papers 4
University of California
Co-authored papers 4
UCD Conway Institute, University College Dublin
Co-authored papers 4
Institute for Systems Biology
Co-authored papers 4
Institute of Chemistry, Federal University of Rio de Janeiro
Co-authored papers 3
University of Texas Health Science Center at San Antonio Texas78229 USA.
Co-authored papers 3
Groningen Research Institute of Pharmacy, University of Groningen
Co-authored papers 3
Institute of Chemistry
Co-authored papers 3
Co-authored papers 3
Princeton University
Co-authored papers 3